LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in people with B-cell cancers like lymphoma that have not responded to prior treatments. The main goals are to find the safest dose and see if the drug can shrink tumors. About 215 adults will take part, and those who benef…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 11:56 UTC
-
Engineered immune cells take aim at stubborn leukemia
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with certain blood cancers (like acute myeloid leukemia) that have come back or not responded to standard care. Researchers take a patient's own immune cells, modify them in the lab to recognize and attack cancer cells carry…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 15, 2026 11:55 UTC